Felzartamab Selectively and Potently Targets CD38+ Antibody-Secreting Cells from Patients with Immune-Mediated Kidney Diseases

Authors: Tess Arenzana Delfino, Kristina M. Ilieva, Karin Landgraf, Rainer Boxhammer, Stefan Steidl, Donna Flesher

Published: 2024-10-28

DOI: 10.1681/asn.2024s1kbcs27

Keywords: No keywords found.

Abstract:
No abstract found.

Source: